Question 1

Does Focus Partners Wealth own ARWR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Focus Partners Wealth holds 30,510 shares of ARWR (Arrowhead Pharmaceuticals), worth $2.5M.

Question 2

How many shares of ARWR does Focus Partners Wealth own?

Accepted Answer

As of its Q2 2026 13F, Focus Partners Wealth holds 30,510 shares of ARWR (Arrowhead Pharmaceuticals).

Question 3

What is Focus Partners Wealth's ARWR position worth?

Accepted Answer

As of its Q2 2026 13F, Focus Partners Wealth's ARWR position is worth $2.5M.

Question 4

Is Focus Partners Wealth buying or selling ARWR?

Accepted Answer

In Q2 2026, Focus Partners Wealth increased its ARWR position by 16,818 shares (+122.8%).

Question 5

When did Focus Partners Wealth first buy ARWR?

Accepted Answer

Focus Partners Wealth first reported ARWR in its Q3 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	30,510	+122.8%	$2.5M	0.0%	$81.51	42
2026-Q1	Decreased	13,692	-32.5%	$858,489	0.0%	$62.70	0
2025-Q4	Decreased	20,300	-8.2%	$1.3M	0.0%	$66.39	0
2025-Q3	Increased	22,110	+24.3%	$1.4M	0.0%	$34.49	31
2025-Q2	Increased	17,795	+9.5%	$281,162	0.0%	$15.80	26
2025-Q1	Decreased	16,252	-3.1%	$207,052	0.0%	$12.74	0
2024-Q4	Increased	16,778	+0.9%	$315,427	0.0%	$18.80	24
2024-Q3	New	16,622	—	$321,969	0.0%	$19.37	33